Gsk (GSK) Inventory (2016 - 2025)
Historic Inventory for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $8.3 billion.
- Gsk's Inventory rose 733.77% to $8.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.3 billion, marking a year-over-year increase of 733.77%. This contributed to the annual value of $7.2 billion for FY2024, which is 596.62% up from last year.
- Latest data reveals that Gsk reported Inventory of $8.3 billion as of Q3 2025, which was up 733.77% from $8.1 billion recorded in Q2 2025.
- In the past 5 years, Gsk's Inventory ranged from a high of $8.8 billion in Q2 2021 and a low of $1.3 billion during Q1 2022
- For the 5-year period, Gsk's Inventory averaged around $7.0 billion, with its median value being $7.3 billion (2024).
- Per our database at Business Quant, Gsk's Inventory tumbled by 8456.43% in 2022 and then skyrocketed by 39197.34% in 2023.
- Over the past 5 years, Gsk's Inventory (Quarter) stood at $7.8 billion in 2021, then dropped by 22.57% to $6.0 billion in 2022, then grew by 13.05% to $6.8 billion in 2023, then rose by 6.63% to $7.3 billion in 2024, then grew by 13.43% to $8.3 billion in 2025.
- Its Inventory was $8.3 billion in Q3 2025, compared to $8.1 billion in Q2 2025 and $7.6 billion in Q1 2025.